Health Affairs April 30, 2019
Russ Montgomery, Tom Valuck, Cynthia A. Bens, Andrea Ferris

Personalized medicine, which targets care based on a patient’s genomics, genetics, medical status, personal circumstances, and care preferences, is transforming health care delivery. Meanwhile, value-based payment is also driving sweeping changes by tying payment to quality. However, the traditional approaches to quality measurement and improvement are based on standardization of care, which fundamentally conflicts with the goals of personalized medicine.

Using oncology as an example, in this blog post we outline three tensions that put quality measurement and personalized medicine into conflict and present recommendations for new approaches to quality measurement that better align with the goals of personalized medicine. Recognizing that quality measures are necessary but not sufficient, we also highlight other opportunities to further align quality and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Precision Medicine, Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article